全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Maintenance of Increased Mouth Opening in Oral Submucous Fibrosis Patient Treated with Nasolabial Flap Technique

DOI: 10.1155/2014/842578

Full-Text   Cite this paper   Add to My Lib

Abstract:

Oral submucous fibrosis (OSMF) is an insidious chronic disease affecting any part of the oral cavity and sometimes the pharynx with epithelial atrophy leading to stiffness of the oral mucosa, causing trismus and inability to eat. However, a more serious complication of this disease is the risk of the development of oral carcinoma. A case of OSMF reported with initial interincisal mouth opening; 8?mm which was treated surgically with nasolabial flap technique followed by active mouth opening exercises for 6 months with Hister’s jaw exerciser. The patient could maintain mouth opening of 32?mm at the end of 18-months followup. The patient was observed closely for any malignant changes in the oral cavity. 1. Introduction Oral submucous fibrosis (OSMF) is an insidious chronic disease affecting any part of the oral cavity and sometimes the pharynx. Although occasionally preceded by and or associated with vesicle formation, it is always associated with juxtaepithelial inflammatory reaction followed by a fibroelastic change of the lamina propria, with epithelial atrophy leading to stiffness of the oral mucosa, causing trismus and inability to eat [1]. OSMF has a high rate of morbidity because it causes progressive inability to open the mouth, resulting in inability to eat and consequent nutritional deficiencies [2]. Mortality rate is significant because it transforms into oral cancer, particularly squamous cell carcinoma at a rate of 7%–30% [2]. Management includes cessation of habit and surgical release of fibrous bands followed by forceful opening of the mouth by coronoidectomy and coverage of surgical defects with nasolabial flap and postoperative active jaw physiotherapy for 6 months [3]. Surgery may induce scar tissue which reduces mouth opening due to scar contraction in mouth closing muscles [4]. Relapse is a common complication that occurs after surgical release of the oral trismus caused by OSMF [5]. A variety of jaw opening devices have been used to treat trismus [6]. The purpose of this paper is to report a definite treatment approach that combines surgery with active physiotherapy to improve the jaw opening and to prevent relapse. Small effort has been made in the present study aiming to endure adequate, functional disease free mouth opening and to detect any developing malignant change at its earliest. 2. Case Report A 24-year-old male patient from India reported with a complaint of increasing difficulty of mouth opening and mastication for the previous 3 years. The patient had a habit of chewing betel nuts four times a day for 5 to 6 years. He

References

[1]  R. Pillai, P. Balaram, and K. S. Reddiar, “Pathogenesis of oral submucous fibrosis: relationship to risk factors associated with oral cancer,” Cancer, vol. 69, no. 8, pp. 2011–2020, 1992.
[2]  V. V. Shevale and R. D. Kalra, “Management of oral sub-mucous fibrosis: a review,” Indian Journal of Dental Sciences, vol. 4, no. 2, 2012.
[3]  R. M. Borle, P. V. Nimonkar, and R. Rajan, “Extended nasolabial flaps in the management of oral submucous fibrosis,” British Journal of Oral and Maxillofacial Surgery, vol. 47, no. 5, pp. 382–385, 2009.
[4]  P. U. Dijkstra, M. W. Sterken, R. Pater, F. K. L. Spijkervet, and J. L. N. Roodenburg, “Exercise therapy for trismus in head and neck cancer,” Oral Oncology, vol. 43, no. 4, pp. 389–394, 2007.
[5]  P. V. Le and M. Gornitsky, “Oral stent as treatment adjunct for oral submucous fibrosis,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 81, no. 2, pp. 148–150, 1996.
[6]  M. D. Stubblefield, L. Manfield, and E. R. Riedel, “A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer,” Archives of Physical Medicine and Rehabilitation, vol. 91, no. 8, pp. 1278–1282, 2010.
[7]  V. K. Hazarey, D. M. Erlewad, K. A. Mundhe, and S. N. Ughade, “Oral submucous fibrosis: study of 1000 cases from central India,” Journal of Oral Pathology and Medicine, vol. 36, no. 1, pp. 12–17, 2007.
[8]  D. G. Adwani, Histopathological studies before and after Kenacort in oral submucous fibrosis [MDS thesis], University of Bombay, Bombay, India, 1982.
[9]  M. V. Naphade and U. M. Naphade, “Major immunoglobulin status and lactate dehydrogenase isozyme profile in oral premalignancy and malignancy,” Dental Dialogue Official Journal of IDA, MSB, vol. 37, no. 1, pp. 16–20, 2011.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413